Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Healthcare Sector Analysis

UpdatedFeb 08, 2026
DataAggregated Company Financials
Companies21
  • 7D-16.8%
  • 3M-0.9%
  • 1Y-47.0%
  • YTD-9.7%

Over the last 7 days, the Healthcare industry has dropped 17%, driven by Novo Nordisk declining 20%. Overall the industry is down 47% in 12 months. As for the next few years, earnings are expected to grow by 3.4% per annum.

Sector Valuation and Performance

Has the Danish Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 08 Feb 2026DKK 1.8tDKK 448.2bDKK 134.9b16.7x13.1x3.9x
Tue, 06 Jan 2026DKK 2.0tDKK 453.8bDKK 136.9b17.2x14.8x4.5x
Thu, 04 Dec 2025DKK 1.9tDKK 454.0bDKK 136.9b16.9x13.5x4.1x
Sat, 01 Nov 2025DKK 1.9tDKK 448.0bDKK 141.9b17.2x13.4x4.3x
Mon, 29 Sep 2025DKK 2.0tDKK 447.4bDKK 141.7b18x14.3x4.5x
Wed, 27 Aug 2025DKK 2.0tDKK 447.5bDKK 141.8b24.3x14.3x4.5x
Fri, 25 Jul 2025DKK 2.5tDKK 423.1bDKK 124.4b30.1x19.8x5.8x
Sun, 22 Jun 2025DKK 2.6tDKK 423.5bDKK 124.6b30.4x20.6x6.1x
Tue, 20 May 2025DKK 2.4tDKK 424.3bDKK 125.1b23.7x19.2x5.7x
Thu, 17 Apr 2025DKK 2.3tDKK 409.2bDKK 121.3b21.8x19.1x5.7x
Sat, 15 Mar 2025DKK 2.8tDKK 409.5bDKK 121.3b24.9x23.5x7x
Mon, 10 Feb 2025DKK 3.3tDKK 408.3bDKK 118.3b28.7x28.1x8.2x
Wed, 08 Jan 2025DKK 3.2tDKK 387.4bDKK 111.3b29.9x28.9x8.3x
Fri, 06 Dec 2024DKK 4.0tDKK 387.3bDKK 111.3b31.6x35.8x10.3x
Sun, 03 Nov 2024DKK 4.0tDKK 372.2bDKK 107.2b34.5x37.1x10.7x
Tue, 01 Oct 2024DKK 4.1tDKK 371.9bDKK 107.1b36.3x38x10.9x
Thu, 29 Aug 2024DKK 4.6tDKK 371.7bDKK 107.1b33.3x43.2x12.4x
Sat, 27 Jul 2024DKK 4.5tDKK 355.4bDKK 106.3b35.9x42.1x12.6x
Mon, 24 Jun 2024DKK 4.9tDKK 355.4bDKK 106.2b34.5x46.6x13.9x
Wed, 22 May 2024DKK 4.7tDKK 355.3bDKK 106.2b37.4x44.2x13.2x
Fri, 19 Apr 2024DKK 4.4tDKK 341.3bDKK 99.6b32.8x44.3x12.9x
Sun, 17 Mar 2024DKK 4.6tDKK 341.2bDKK 99.6b39.3x46.5x13.6x
Tue, 13 Feb 2024DKK 4.3tDKK 340.5bDKK 98.6b33.9x43.2x12.5x
Thu, 11 Jan 2024DKK 3.8tDKK 320.5bDKK 90.0b34.1x42.5x11.9x
Sat, 09 Dec 2023DKK 3.5tDKK 320.6bDKK 90.0b33.8x38.9x10.9x
Mon, 06 Nov 2023DKK 3.5tDKK 318.7bDKK 90.3b29.1x39.2x11.1x
Wed, 04 Oct 2023DKK 3.4tDKK 305.6bDKK 82.2b32.2x40.9x11x
Fri, 01 Sep 2023DKK 3.4tDKK 305.2bDKK 82.1b35.6x41.1x11.1x
Sun, 30 Jul 2023DKK 2.9tDKK 287.2bDKK 75.5b37.2x38.5x10.1x
Tue, 27 Jun 2023DKK 3.0tDKK 287.1bDKK 75.5b39.4x39.2x10.3x
Thu, 25 May 2023DKK 3.1tDKK 287.1bDKK 75.5b41.2x40.9x10.8x
Sat, 22 Apr 2023DKK 3.2tDKK 272.6bDKK 68.5b44x46.7x11.7x
Mon, 20 Mar 2023DKK 2.7tDKK 292.6bDKK 69.2b37.6x39.6x9.4x
Wed, 15 Feb 2023DKK 2.8tDKK 289.4bDKK 68.9b40.4x40.6x9.7x
Price to Earnings Ratio

40.6x


Total Market Cap: DKK 2.8tTotal Earnings: DKK 68.9bTotal Revenue: DKK 289.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Healthcare Sector Price to Earnings3Y Average 33.2x202420252026
Current Industry PE
  • Investors are pessimistic on the Danish Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 13.1x which is lower than its 3-year average PE of 33.2x.
  • The 3-year average PS ratio of 9.4x is higher than the industry's current PS ratio of 3.9x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 25% per year over the last three years.
  • Revenues for these companies have grown 16% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare sector?

DK Market-7.01%
Healthcare-16.80%
Healthtech-1.74%
Biotech-2.80%
Medical Equipment-8.12%
Healthcare Services-10.30%
Pharma-19.16%
Life Sciences-20.89%
Industry PE
  • Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio of 331x.
    • Analysts are expecting annual earnings growth of 85.3%, which is higher than its past year's earnings decline of 99.7% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 96% over the next 5 years.
  • In contrast, the Life Sciences industry is expected to see its earnings decline by 23% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ALK B ALK-AbellóDKK 217.604.8%
+DKK 2.2b		36.0%PE43.7x
AMBU B AmbuDKK 87.903.3%
+DKK 705.5m		-34.2%PE42.9x
BAVA Bavarian NordicDKK 193.400.7%
+DKK 70.8m		10.3%PE6.1x
MONSO MonsensoDKK 0.162.6%
+DKK 298.4k		-39.5%PS1.1x

Latest News

NOVO B
DKK 295.50
Novo Nordisk
7D
-20.0%
1Y
-53.0%

Novo Nordisk (CPH:NOVO B) Is Paying Out A Larger Dividend Than Last Year

Feb 08
Novo Nordisk (CPH:NOVO B) Is Paying Out A Larger Dividend Than Last Year
CHEMM
DKK 432.00
ChemoMetec
7D
-29.1%
1Y
-23.3%

ChemoMetec A/S' (CPH:CHEMM) 40% Cheaper Price Remains In Tune With Earnings

Feb 08
ChemoMetec A/S' (CPH:CHEMM) 40% Cheaper Price Remains In Tune With Earnings
AMBU B
DKK 87.90
Ambu
7D
3.3%
1Y
-34.2%

Earnings Miss: Ambu A/S Missed EPS By 8.7% And Analysts Are Revising Their Forecasts

Feb 08
Earnings Miss: Ambu A/S Missed EPS By 8.7% And Analysts Are Revising Their Forecasts
HLUN B
DKK 37.46
H. Lundbeck
7D
-11.1%
1Y
-11.2%
COLO B
DKK 493.50
Coloplast
7D
-7.9%
1Y
-37.2%
DEMANT
DKK 187.40
Demant
7D
-15.0%
1Y
-29.3%
EMBLA
DKK 30.00
Embla Medical hf
7D
-5.4%
1Y
-12.5%

Embla Medical hf. (CPH:EMBLA) Just Released Its Full-Year Earnings: Here's What Analysts Think

Feb 06
Embla Medical hf. (CPH:EMBLA) Just Released Its Full-Year Earnings: Here's What Analysts Think
BAVA
DKK 193.40
Bavarian Nordic
7D
0.7%
1Y
10.3%
ZEAL
DKK 407.30
Zealand Pharma
7D
-3.0%
1Y
-44.1%
GMAB
DKK 1,958.00
Genmab
7D
-3.2%
1Y
41.4%

GMAB: Phase 3 Data, AI Adoption And 2026 Readout Will Shape Outlook

Genmab’s analyst fair value estimate has moved modestly higher to DKK 2,188.94. Analysts point to updated assumptions around slightly lower discount rates, adjusted revenue growth and profit margin expectations, and a recalibrated future P/E multiple as the key drivers behind the refreshed price targets.
ALK B
DKK 217.60
ALK-Abelló
7D
4.8%
1Y
36.0%
MONSO
DKK 0.16
Monsenso
7D
2.6%
1Y
-39.5%